Seminar 2 – Advanced Therapy Medicinal Products

Accelerating Development of ATMP Technology to Phase 1 Clinical Studies and Beyond

Seminar 2 – Advanced Therapy Medicinal Products

15:45 - 16:45 Plenary Room A
The session is dedicated to SMEs involved in the development of Advanced Therapy Medicinal Products (ATMPs). The panel will discuss different strategies for SMEs, including going public, pharma collaborations and what big pharma companies are looking for when scouting external innovations.

Hosted by:

Swelife

Swelife

Moderator(s): Dr. Christina Östberg Lloyd - Clinical Medical Regulatory Director, Novo Nordisk & Chairman, Swelife

Speaker(s):
Prof. Malin Parmar - Associate Professor, Lund University Mr. Leo Groenewegen - Business Developer, NextCell Pharma Dr. Carlos De Sousa - CEO, Immunicum Dr. Christoph Varenhorst - Medical Director, Pfizer Dr. Cecilia Ahlin - Medical Head Oncology, Novartis Sweden Dr. Björn Odlander - Managing Partner, HealthCap Mr. Daniel Bolanowski - Senior Analyst, Arctic Fund Management

full program